Californians in danger of a heart attack or stroke now have help reducing a key risk factor.
One of the state’s largest commercial insurers, Blue Shield of California, has eased access to PCSK9 inhibitors. Called a “game changer in cholesterol management,” the medication can significantly reduce LDL cholesterol for patients who don’t respond well to statins.